FN1 and myeloid sarcoma: Thus, factors that interfere with alternative fibronectin splicing and TLR3-mediated signaling, and/or factors that prevent the decreased fibronectin-integrin binding aid to proper fibril formation, thereby precluding aggregation, are potential targets to aid efficient remyelination in MS.